News | April 01, 2025
Akums launches Ripasudil + Timolol combination for glaucoma treatment
The new combination therapy offers a dual mechanism of action for superior intraocular pressure control
The new combination therapy offers a dual mechanism of action for superior intraocular pressure control
Bio-Thera will maintain responsibility for development, manufacturing, and supply of BAT2206 and BAT2506
Alembic Pharmaceuticals Ltd. and Amlan International sign exclusive strategic commercial agreement to make poultry health innovations accessible to Indian farmers and integrators
This program, titled "Food Supplementation and Capacity Building Support for Improved Nutrition in Malinao, Aklan," aligns with the country’s national health
The products will be manufactured in Goa India and marketed & distributed in Australian markets
The product is being recalled because the infusion bag is incorrectly labeled as Levetiracetam in 0.82% Sodium Chloride Injection 500 mg/100 mL single-dose bag, while the aluminum overwrap packaging correctly identifies the product as Levetiracetam in 0.75% Sodium Chloride Injection 1,000 mg/100 m
Amexel aims to generate revenue through facilitation services and a profit-sharing model linked to the commercialization of products
These appointments align with the group’s philosophy of having a strong and independent board with exceptional industry experts, ensuring strategic guidance and effective governance
Empagliflozin and its Fixed Drug Combinations (FDCs) have been launched under the brand names Glempa, Glempa –L and Glempa-M
Announces Rs. 317 crore investment in new recycling plant
Subscribe To Our Newsletter & Stay Updated
